Kathryn Pula

407 total citations
15 papers, 267 citations indexed

About

Kathryn Pula is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Kathryn Pula has authored 15 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Kathryn Pula's work include Hemodynamic Monitoring and Therapy (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Blood Pressure and Hypertension Studies (3 papers). Kathryn Pula is often cited by papers focused on Hemodynamic Monitoring and Therapy (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Blood Pressure and Hypertension Studies (3 papers). Kathryn Pula collaborates with scholars based in United States. Kathryn Pula's co-authors include Edmund J. Sybertz, Thomas Baum, R.W. Watkins, Maria A. Rivelli, Joseph C. Glennon, Elijah H. Gold, Robert W. Watkins, Steven D. Nelson, Subbarao Vemulapalli and Sarah E. Nelson and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Journal of Cardiovascular Pharmacology.

In The Last Decade

Kathryn Pula

15 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Pula United States 9 122 73 60 35 33 15 267
P Mentz Germany 10 122 1.0× 98 1.3× 48 0.8× 59 1.7× 47 1.4× 47 316
R. W. Sevy United States 11 145 1.2× 59 0.8× 50 0.8× 22 0.6× 39 1.2× 34 396
P. Braquet France 13 77 0.6× 103 1.4× 78 1.3× 36 1.0× 27 0.8× 44 357
C D Evans United States 10 92 0.8× 154 2.1× 43 0.7× 20 0.6× 80 2.4× 15 437
K.‐U. Seiler Germany 11 38 0.3× 98 1.3× 85 1.4× 37 1.1× 28 0.8× 20 324
Kenneth Y. Chan United States 10 40 0.3× 88 1.2× 49 0.8× 78 2.2× 30 0.9× 18 334
Michael G. Wendling United States 10 56 0.5× 51 0.7× 46 0.8× 26 0.7× 37 1.1× 14 250
M. Oka Canada 10 47 0.4× 65 0.9× 50 0.8× 64 1.8× 31 0.9× 20 325
Juro Ueda Japan 12 98 0.8× 91 1.2× 69 1.1× 39 1.1× 37 1.1× 35 328
Julia A. Terrell United States 7 145 1.2× 44 0.6× 61 1.0× 14 0.4× 19 0.6× 7 371

Countries citing papers authored by Kathryn Pula

Since Specialization
Citations

This map shows the geographic impact of Kathryn Pula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Pula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Pula more than expected).

Fields of papers citing papers by Kathryn Pula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Pula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Pula. The network helps show where Kathryn Pula may publish in the future.

Co-authorship network of co-authors of Kathryn Pula

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Pula. A scholar is included among the top collaborators of Kathryn Pula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Pula. Kathryn Pula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Pula, Kathryn, et al.. (1993). NG-Nitro-L-arginine Methyl Ester Does Not Affect Balloon Catheter-Induced Intimal Hyperplasia in Rats. Biochemical and Biophysical Research Communications. 197(1). 304–309. 11 indexed citations
2.
Watkins, R.W., et al.. (1990). Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol.. PubMed. 302. 158–73. 1 indexed citations
3.
Watkins, Robert W., et al.. (1988). Systemic Effects Resulting from Topical Ocular Administration of SCH 33861, a Novel ACE Inhibitor Ocular Hypotensive Agent. Journal of Ocular Pharmacology and Therapeutics. 4(2). 93–100. 10 indexed citations
4.
Watkins, Robert W., et al.. (1988). Effects of the Antihypertensive Dilevalol on Aortic Compliance in Anesthetized Dogs. Journal of Cardiovascular Pharmacology. 12(1). 42–50. 7 indexed citations
5.
Pula, Kathryn, et al.. (1988). Comparative effects of verapamil, diltiazem and nifedipine on aortic compliance in anesthetized dogs.. PubMed. 293. 134–42. 4 indexed citations
6.
Watkins, Robert W., et al.. (1987). Effects of the Antihypertensive Dilevalol on Large Artery Compliance in Anesthetized Dogs. Journal of Cardiovascular Pharmacology. 10. S58–S63. 8 indexed citations
7.
Watkins, Robert W., et al.. (1987). Effects of the Antihypertensive Dilevalol on Large Artery Compliance in Anesthetized Dogs. Journal of Cardiovascular Pharmacology. 10. S58–S63. 3 indexed citations
8.
Watkins, Robert W., et al.. (1987). Effects of the Antihypertensive Dilevalol on Large Artery Compliance in Anesthetized Dogs. Journal of Cardiovascular Pharmacology. 10(Supplement). S58–S63. 1 indexed citations
9.
Pula, Kathryn, et al.. (1987). Effects of spiraprilic acid, an angiotensin converting enzyme inhibitor, on large artery compliance in anesthetized dogs.. PubMed. 290(2). 222–34. 3 indexed citations
10.
Sybertz, Edmund J., R.W. Watkins, Thomas Baum, Kathryn Pula, & Maria A. Rivelli. (1985). Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.. Journal of Pharmacology and Experimental Therapeutics. 232(1). 156–162. 49 indexed citations
11.
Baum, Thomas, Edmund J. Sybertz, Robert W. Watkins, et al.. (1983). Antihypertensive Activity of SCH 31846, a Non-Sulfhydryl Angiotensin-Converting Enzyme Inhibitor. Journal of Cardiovascular Pharmacology. 5(4). 655–667. 16 indexed citations
12.
Sybertz, Edmund J., Thomas Baum, Ho Sam Ahn, et al.. (1983). Angiotensin-Converting Enzyme Inhibitory Activity of SCH 31846, a New Non-Sulfhydryl Inhibitor. Journal of Cardiovascular Pharmacology. 5(4). 643–654. 18 indexed citations
13.
Sybertz, Edmund J., et al.. (1982). Studies on the Mechanism of the Acute Antihypertensive and Vasodilator Actions of Several β-Adrenoceptor Antagonists. Journal of Cardiovascular Pharmacology. 4(5). 749–758. 25 indexed citations
14.
Sybertz, Edmund J., et al.. (1981). Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.. Journal of Pharmacology and Experimental Therapeutics. 218(2). 435–443. 61 indexed citations
15.
Baum, Thomas, R.W. Watkins, Edmund J. Sybertz, et al.. (1981). Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.. Journal of Pharmacology and Experimental Therapeutics. 218(2). 444–452. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026